Infections, Human Immunodeficiency Virus and Herpesviridae
2 competing products in clinical development for Infections, Human Immunodeficiency Virus and Herpesviridae.
Pipeline by Phase
Phase 12
All Products (2)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Dolutegravir 50 mg tablet + Dolutegravir 50 mg oral granules | Shionogi | Phase 1 | Completed | 29 |
| GSK1349572 + Efavirenz | Shionogi | Phase 1 | Completed | 29 |